Ignite Creation Date:
2024-05-06 @ 9:11 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02924402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2016-09-14
Brief Title:
Study to Evaluate Safety and Tolerability of XmAb13676 Plamotamab in Patients With CD20-expressing Hematologic Malignancies
Sponsor:
Xencor Inc
Organization:
Xencor Inc
Organization Data
Organization:
Xencor Inc
Class:
INDUSTRY
Study ID:
XmAb13676-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xencor Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ICON Clinical Research | INDUSTRY |